Want to see OFIX full AI Analyst Report?
Total Valuation
Orthofix Medical has a market cap or net worth of $401.79M. The enterprise value is $487.20M.
Market Cap$401.79M
Enterprise Value$487.20M
Share Statistics
Orthofix Medical has 40,421,654 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding40,421,654
Owned by Insiders14.58%
Owned by Institutions51.99%
Financial Efficiency
Orthofix Medical’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -10.01%.
Return on Equity (ROE)-0.20
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-10.01%
Return on Capital Employed (ROCE)-0.10
Revenue Per Employee508.86K
Profits Per Employee-57.05K
Employee Count1,616
Asset Turnover0.97
Inventory Turnover7.92
Valuation Ratios
The current PE Ratio of Orthofix Medical is ―. Orthofix Medical’s PEG ratio is 0.22.
PE Ratio―
PS Ratio0.74
PB Ratio1.34
Price to Fair Value1.34
Price to FCF-472.73
Price to Operating Cash Flow11.52
PEG Ratio0.22
Income Statement
In the last 12 months, Orthofix Medical had revenue of 822.31M and earned -92.19M in profits. Earnings per share was -2.28.
Revenue822.31M
Gross Profit551.71M
Operating Income-68.47M
Pretax Income-90.81M
Net Income-92.19M
EBITDA-22.35M
Earnings Per Share (EPS)-2.28
Cash Flow
In the last 12 months, operating cash flow was 34.91M and capital expenditures -38.54M, giving a free cash flow of -3.63M billion.
Operating Cash Flow34.91M
Free Cash Flow-3.63M
Free Cash Flow per Share-0.09
Dividends & Yields
Orthofix Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.03
52-Week Price Change-10.61%
50-Day Moving Average10.62
200-Day Moving Average13.24
Relative Strength Index (RSI)51.70
Average Volume (3m)212.06K
Important Dates
Orthofix Medical upcoming earnings date is Aug 11, 2026, After Close (Confirmed).
Last Earnings DateMay 5, 2026
Next Earnings DateAug 11, 2026
Ex-Dividend Date―
Financial Position
Orthofix Medical as a current ratio of 2.45, with Debt / Equity ratio of 53.86%
Current Ratio2.45
Quick Ratio2.24
Debt to Market Cap0.31
Net Debt to EBITDA-6.59
Interest Coverage Ratio-3.92
Taxes
In the past 12 months, Orthofix Medical has paid 1.38M in taxes.
Income Tax1.38M
Effective Tax Rate-0.02
Enterprise Valuation
Orthofix Medical EV to EBITDA ratio is -33.64, with an EV/FCF ratio of -587.85.
EV to Sales0.91
EV to EBITDA-33.64
EV to Free Cash Flow-587.85
EV to Operating Cash Flow22.55
Balance Sheet
Orthofix Medical has $120.28M in cash and marketable securities with $234.39M in debt, giving a net cash position of -$114.11M billion.
Cash & Marketable Securities$120.28M
Total Debt$234.39M
Net Cash-$114.11M
Net Cash Per Share-$2.82
Tangible Book Value Per Share$4.57
Margins
Gross margin is 69.02%, with operating margin of -8.33%, and net profit margin of -11.21%.
Gross Margin69.02%
Operating Margin-8.33%
Pretax Margin-11.04%
Net Profit Margin-11.21%
EBITDA Margin-2.72%
EBIT Margin-8.92%
Analyst Forecast
The average price target for Orthofix Medical is $15.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$15.00
Price Target Upside24.90% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast2.59%
EPS Growth Forecast59.39%